SONG, DAE HAE,宋大海,KIM, MIN YOUNG,金玟永,PARK, YOUNG JIN,朴永振,KANG, EUN HEE,姜殷姬,JUNG, SUNG YOUB,郑圣烨,鄭聖燁,KWON, SE CHANG,权世昌,權世昌,LEE, GWAN SUN,李宽淳,李寬淳
申请号：
TW097145881
公开号：
TWI403331B
申请日:
2008.11.27
申请国别(地区):
TW
年份:
2013
代理人:
摘要：
The present invention relates to a composition for treating obesity-related diseases comprising an insulinotropic peptide conjugate, more particularly, to a composition for treating obesity-related diseases comprising a conjugate prepared by covalently linking the insulinotropic peptide with a carrier substance via a non-peptidyl linker, and a method for treating obesity-related diseases by using the same. In particular, the composition for treating obesity-related diseases according to the present invention remarkably improves the efficacy of suppressing food intake and its duration to reduce body weight and body fat, thereby being useful for the treatment of obesity-related diseases.本發明係關於用於治療肥胖相關性疾病的組成物，其包含促胰島素肽共軛物；更詳言之，本發明係關於用於治療肥胖相關性疾病的組成物，其包含藉由透過非肽基型聯結子共價聯結促胰島素肽與載體物質而製備之共軛物，以及使用此組成物治療肥胖相關性疾病的方法。特定言之，如本發明之用於治療肥胖相關性疾病的醫藥組成物明顯改善對於食物攝取的抑制效果以及其減少體重及體脂肪的持續期間，因此對於肥胖相關性疾病之治療有效。
